Baz M, Abed Y, Boivin G. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res. 2006 Nov 20
There is a limited information with regard to the neuraminidase (NA) mutations conferring resistance to peramivir and zanamivir in the influenza N1 background. In this study, an influenza A/WSN/33 (H1N1) recombinant virus was passaged under peramivir or zanamivir pressure. The peramivir-selected variant had a H274Y mutation in the neuraminidase (NA) gene conferring resistance to peramivir and oseltamivir but susceptibility to zanamivir. The zanamivir-selected variant had a massive deletion in the region encoding the NA active center and an A200T hemagglutinin mutation. This variant exhibited reduced susceptibility to zanamivir with a drug-dependent phenotype.
See Also:
Latest articles in those days:
- [preprint]Serological Evidence of Widespread Exposure to H5 Avian Influenza Virus in Arctic Foxes in Svalbard, Norway 1 hours ago
- Limited added benefit of seasonal influenza vaccination before A(H5) vaccination in mice and ferrets challenged with A(H5N1) 6 hours ago
- Emergence of Novel Highly Pathogenic Avian Influenza Virus A(H5N1) Clade 2.3.4.4b in Commercial Poultry, Bangladesh 6 hours ago
- Molecular Epidemiology and Evolution of Swine Influenza A Viruses, Vietnam, 2020-2024 7 hours ago
- Isothermal Detection of Influenza D Virus using Reverse Transcription Loop-Mediated Isothermal Amplification 7 hours ago
[Go Top] [Close Window]


